Diazepam belongs to which therapeutic class?

A. Antidepressants modulate monoamine neurotransmission by inhibiting the reuptake of serotonin or norepinephrine. Diazepam does not possess these pharmacological properties or clinical indications for treating depressive disorders. It is chemically distinct from selective serotonin reuptake inhibitors and tricyclic antidepressants. B. Diazepam is an antianxiety agent that functions as a benzodiazepine. It enhances the inhibitory effects of gamma-aminobutyric acid by binding to the GABA-A receptor complex. This increases chloride ion conductance, resulting in neuronal hyperpolarization and reduced central nervous system excitability. C. Antiparkinson agents typically aim to restore dopamine levels or antagonize acetylcholine within the striatum. Diazepam has no effect on dopaminergic pathways or the motor symptoms associated with Parkinson disease. It is not indicated for the management of neurodegenerative movement disorders. D. Antimanic agents, such as lithium, are utilized to stabilize mood in bipolar disorder through various intracellular signaling pathways. Diazepam lacks the specific clinical efficacy and regulatory approval for treating acute mania. It is primarily used for its sedative, anxiolytic, and muscle relaxant properties.